glp-1 for depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Do GLP-1 agonists like Ozempic

DOI: 10.1007/s00109-016-1488-y

Bures, T., et al

A 2010 study using the Broad Institute's Connectivity Map database found that GHK-Cu at physiologic doses modulated approximately 31% of the 16,000+ human genes evaluated, shifting gene expression toward a more youthful pattern

There is limited data about exactly how GLP-1 RAs affect fertility, pregnancy, and breastfeeding

This finding could pave the way for more targeted treatments that go beyond blood sugar management to directly address kidney deterioration and cardiovascular risks in diabetes

Ozempic mimics the effects of this naturally occurring digestive hormone and slows the movement of food in the digestive tract, regulates blood sugar, and in the long term, causes weight loss